04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024
7:55 PM | Immunocore (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/11/2024
7:19 AM | FMR LLC (Filed by)
Immunocore (Subject)
| Form SC 13G | |
03/07/2024
8:45 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:19 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:33 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:46 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:15 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:57 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
10:00 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/01/2024
4:25 PM | BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
01/05/2024
3:17 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:19 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:55 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:51 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:52 PM | Immunocore (Issuer)
Kaul Siddharth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:53 PM | Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:54 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:55 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:57 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:41 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:42 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:43 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:45 PM | Coy Travis Alan (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:47 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:25 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:30 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
12:54 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
7:33 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
8:51 AM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
6:09 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad) A strange new era for mankind is upon us...
And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day.
Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... |
11/06/2023
6:20 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
3:31 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
1:40 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
08/25/2023
5:10 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
2:44 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
7:28 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/14/2023
3:21 PM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2023
4:28 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
4:17 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
06/05/2023
5:04 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
8:20 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
6:27 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2023
8:29 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
